News Daily News Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More Michael O'Riordan December 06, 2024
News Conference News PCR London Valves 2024 Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI Michael O'Riordan December 02, 2024
News Daily News FDA Approves Varipulse Pulsed-Field Ablation System for AF Michael O'Riordan November 07, 2024
News Conference News TCT 2024 TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR Michael O'Riordan October 29, 2024
News Opinion Editor's Corner TCT 2024 What’s Going to Be Big at TCT 2024? Michael O'Riordan October 17, 2024
News Daily News New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery Michael O'Riordan September 24, 2024
News Daily News Little Pre- and Postmarket Testing for Most Recalled CV Devices Michael O'Riordan September 16, 2024
News Daily News AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients Michael O'Riordan August 26, 2024
News Opinion Editor's Corner Olympic Hearts: Screening for CVD Among Team USA’s Athletes Michael O'Riordan July 31, 2024
News Daily News Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF Michael O'Riordan July 09, 2024
News Conference News NY Valves 2024 AV Block Common After Transcatheter Tricuspid Valve Replacement for TR Michael O'Riordan June 07, 2024
News Conference News HRS 2024 Goal of Arrhythmia Care in Athletes is a Return to Play: HRS Consensus Michael O'Riordan May 23, 2024
News Daily News Climbing Everest? Cardiac Arrhythmias Join Other Fabled Risks Michael O'Riordan April 04, 2024
News Daily News Physicians (Mostly) Negative on Private Equity in Healthcare Michael O'Riordan March 13, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
News Daily News Experts Warn of Looming Private Equity Interest in Cardiology Care Michael O'Riordan January 15, 2024
News Daily News Steady Rise in CVD Deaths Linked to Substance Abuse, US Data Show Michael O'Riordan January 10, 2024